about
Artificial tears potpourri: a literature reviewPreservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye dropsOcular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia.Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative systemMicrobial contamination of preservative free eye drops in multiple application containers.The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.Bioavailability of fluorescein from a new drug delivery system in human eyes.A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma.Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis.Autologous serum eyedrops: literature review and implications for transfusion medicine specialists.An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.Overview of the [corrected] travoprost /timolol BAK-free fixed combination.Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface.Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.Safety of treatments for primary Sjögren's syndrome.PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.Ocular surface disease in patients under topical treatment for glaucoma.Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.Depressed visual field and mood are associated with sleep disorder in glaucoma patients.Analysis of the effects of preservative-free tafluprost on the tear proteome.Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface.β-Alkylated oligomaltosides as new alternative preservatives: antimicrobial activity, cytotoxicity and preliminary investigation of their mechanism of action.Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects.Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
P2860
Q24561486-8C6A2053-33B2-452B-8B51-64CEE7575FCCQ27009083-A0F2591E-6658-43A4-8074-54D34638A248Q33374316-08E281F5-79A7-4E4E-951B-13B9445419EEQ33800691-0CC7F172-E78D-45A1-BD8B-46D2C707A227Q33879039-2276BFEE-3306-4578-B36C-8DBE9C345582Q34564345-E2509FAD-6EBD-410D-B2AE-A56E428608E9Q34769319-C611FE5B-9C1C-425E-97C2-D0451C6A303CQ35591645-5D2B762C-E4B0-4623-8EA2-4B22706B307CQ35906365-97E4BEE4-CB51-4848-A2E6-A69A3CB93148Q36280601-BA7613CB-D5BD-48EC-A8FC-E343F0B1FD97Q37137885-AD99FD98-52DC-40A0-856E-8F9AA303373AQ37247297-D7B72243-87F3-4DA9-BC8D-E6CE06AD32B0Q37987586-12AA2DAA-9215-456B-A29B-3D5FC03BA9AEQ38096951-6C486779-7EC5-4C09-ABC8-9E0B0DF18756Q38133883-76BF832D-B63E-4DBD-AB7D-49F635377ADCQ38711144-9A8329D7-13AC-45F9-8488-07C41DEDBB5EQ38884492-77E2A848-0983-4ABE-95A9-D0E603335BCCQ39492528-03DF0775-C13A-4191-9290-BB709F11AF73Q40204404-D51B2C0C-DC80-487C-97FC-2AB79E36AD86Q41154638-A5969374-838A-4AD6-B55B-D308700A552DQ41231339-07AE6C39-4998-41E6-8A42-A1A4A084AEA3Q41359153-086D4B68-4980-4DAD-9D65-63D9851C0864Q41668980-89D655D6-AE3F-4FD2-92EA-CF4474F6902EQ43021428-DE4BB02A-9660-43F7-8DB6-843B856F469FQ45895559-2FB75F90-ADF9-475E-BD31-2643B03AC8DAQ47282862-B59E8427-C7CC-4AAE-9901-1D907780021EQ57378488-168C5DD8-CFF6-44BE-A523-257D6B82E0FD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Ocular tolerance of preservatives and alternatives.
@ast
Ocular tolerance of preservatives and alternatives.
@en
Ocular tolerance of preservatives and alternatives.
@nl
type
label
Ocular tolerance of preservatives and alternatives.
@ast
Ocular tolerance of preservatives and alternatives.
@en
Ocular tolerance of preservatives and alternatives.
@nl
prefLabel
Ocular tolerance of preservatives and alternatives.
@ast
Ocular tolerance of preservatives and alternatives.
@en
Ocular tolerance of preservatives and alternatives.
@nl
P2093
P1476
Ocular tolerance of preservatives and alternatives.
@en
P2093
Joachim M Mayer
Pascal Furrer
Robert Gurny
P304
P356
10.1016/S0939-6411(01)00246-6
P407
P577
2002-05-01T00:00:00Z